AE9C90CB: A Novel, Bladder-Selective Muscarinic Receptor Antagonist for the Treatment of Overactive Bladder

British Journal of Pharmacology - United States
doi 10.1111/j.1476-5381.2010.00752.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

OnabotulinumtoxinA for the Treatment of Overactive Bladder

Research and Reports in Urology
Urology
2014English

Discovery of Vibegron: A Potent and Selective 3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

English

Mirabegron &Ndash; A Selective &Szlig;3-Adrenoreceptor Agonist for the Treatment of Overactive Bladder

Research and Reports in Urology
Urology
2012English

Botulinum Toxin a for the Treatment of Overactive Bladder

Toxins
MutagenesisToxicologyHealth
2016English

Stepwise Treatment for Overactive Bladder Is Prudent

Canadian Urological Association Journal
Urology
2017English

Sacral Neuromodulation for Treatment of Overactive Bladder: A Review

Revista de Medicina
2018English

Correction To: Imidafenacin for the Treatment of Overactive Bladder

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2013English

Botulinum Toxin-A for the Treatment of Overactive Bladder: UK Contributions

Journal of Clinical Urology
SurgeryUrology
2013English

Pelvic Electrical Neuromodulation for the Treatment of Overactive Bladder Symptoms

Advances in Urology
GynecologyUrologyObstetrics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy